Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 11:55 PM
NCT ID:
NCT05201794
Pre Assignment Details:
HHCs included family members, acquaintances, co-workers, and community contacts, who were asymptomatic at screening (no clinical dengue symptoms). For safety assessments, although dosing stopped at Day 28, safety data through Day 50 were included in double-blind (DB) prophylactic phase due to drug's extended half-life (\~10 days).
Recruitment Details:
Of 1595 enrolled participants (those who signed informed consent form \[ICF\]): 616 were index cases, 979 were household contacts (HHCs) identified from index cases. Of 616, 411 met the eligibility criteria for index case population (those who signed ICF and had a laboratory-confirmed dengue infection) and are reported below. Out of 979 HHCs, 128 were screen failures. Per plan, index cases were not included in any analysis and 851 randomized HHCs were included in the analysis.
Study:
NCT05201794
Study Brief:
Results Section:
NCT05201794